CCM
BMY icon

CrestPoint Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

CrestPoint Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.81M Hold
29,600
– – 1.01% 24
2017
Q3 		$1.89M Sell
29,600
-2,300
-7% -$134K 0.84% 26
2017
Q2 		$1.78M Buy
31,900
+10,000
+46% +$544K 0.83% 28
2017
Q1 		$1.19M Buy
21,900
+1,000
+5% +$54.8K 0.57% 57
2016
Q4 		$1.22M Buy
20,900
+1,000
+5% +$54.7K 0.61% 50
2016
Q3 		$1.07M Buy
19,900
+7,100
+55% +$456K 0.55% 58
2016
Q2 		$941K Buy
12,800
+600
+5% +$42.4K 0.5% 73
2016
Q1 		$779K Buy
12,200
+1,400
+13% +$88.3K 0.42% 91
2015
Q4 		$743K Sell
10,800
-700
-6% -$46.3K 0.42% 86
2015
Q3 		$681K Sell
11,500
-6,400
-36% -$406K 0.39% 96
2015
Q2 		$1.19M Buy
17,900
+400
+2% +$26.4K 0.63% 49
2015
Q1 		$1.13M Buy
17,500
+13,300
+317% +$833K 0.59% 54
2014
Q4 		$248K Hold
4,200
– – 0.13% 203
2014
Q3 		$215K Sell
4,200
-600
-13% -$30K 0.13% 202
2014
Q2 		$233K Sell
4,800
-100
-2% -$4.93K 0.14% 192
2014
Q1 		$255K Sell
4,900
-1,100
-18% -$58.5K 0.16% 184
2013
Q4 		$319K Buy
+6,000
New +$306K 0.21% 157

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CrestPoint Capital Management's BMY Position: Q4 2017 in Review

CrestPoint Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q4 2017 at 29,600 shares worth $1.81M. The position accounts for 1.01% of the portfolio, ranked #24.

CrestPoint Capital Management first reported a position in BMY in Q4 2013 and has held it in 17 quarters since. The position peaked at $1.89M in Q3 2017. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • CrestPoint Capital Management held 29,600 shares of Bristol-Myers Squibb worth $1.81M as of Q4 2017.
  • CrestPoint Capital Management left its Bristol-Myers Squibb share count unchanged in Q4 2017.
  • Bristol-Myers Squibb made up 1.01% of CrestPoint Capital Management's portfolio in Q4 2017, its #24 holding.
  • CrestPoint Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 17 quarters since.
  • CrestPoint Capital Management's Bristol-Myers Squibb position peaked at $1.89M in Q3 2017.
  • 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.